dr. overman discusses updated findings of checkmate-142 in patients with msi-h mcrc
Published 7 years ago • 234 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
1:08
dr. overman discusses nivolumab in patients with dmmr/msi h mcrc
-
1:03
dr. nelson on the checkmate-142 trial in msi-h/dmmr mcrc
-
1:24
dr. overman on updated findings with nivolumab in metastatic crc
-
1:14
dr. lenz on updated results of the checkmate-142 trial in mcrc
-
1:42
dr. overman on the impact of nivolumab in mcrc
-
2:02
hrqol findings from checkmate 8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
1:34
checkmate-142: updated data from msi high metastatic colon cancer patients
-
2:15
dr. overman discusses redos study in mcrc
-
1:11
checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
0:59
checkmate 8hw: hrqol outcomes of nivolumab and ipilimumab in msi-h/dmmr mcrc
-
1:15
dr. overman discusses progress with immunotherapy in gi cancer
-
4:31
checkmate142: checkpoint combination therapy in first-line colorectal cancer
-
0:53
dr. lenz on the safety profile of checkmate-142 trial in crc
-
1:08
dr. ahn on the keynote-177 trial in newly diagnosed msi-h/dmmr mcrc
-
1:04
dr. halfdanarson on the keynote-177 trial in msi-h/dmmr mcrc
-
1:00
steven j. cohen, md, outlines the results of the checkmate 142 study in mcrc patients
-
1:26
dr. andre on nivolumab plus ipilimumab in dmmr/msi-h mcrc
-
2:10
strong: fixed-dose durvalumab for utc
-
9:24
msi status and immunotherapy in advanced colorectal cancer